Myocardial infarction (MI) is one of the leading causes of death in Western countries. An
early diagnosis decreases subsequent severe complications such as wall remodeling or …

Mounting experimental and clinical evidence has revealed that adaptive immune
mechanisms targeting myocardial antigens are triggered by different forms of cardiac injury …

Inflammation is a crucial factor in the development and progression of cardiovascular
diseases (CVD). Cardiac remodeling in the presence of persistent inflammation leads to …

Drug repurposing, also known as drug repositioning, entails the application of pre-approved
or formerly assessed drugs having potentially functional therapeutic amalgams for curing …

Myocardial ischemia-reperfusion injury (MIRI) is a complex process that occurs when blood
flow is restored after myocardium infarction (MI) with exacerbated tissue damage …

Cardiovascular disease (CVD) is a major cause of morbidity and mortality in patients with
chronic kidney disease (CKD), especially in end-stage renal disease (ESRD) patients and …

Therapeutic vaccines are a promising alternative for active immunotherapy for different types
of cancers. Therapeutic cancer vaccines aim to prevent immune system responses that are …

Cardiovascular diseases and liver diseases are closely related. Non-alcoholic fatty liver
disease has the same risk factors as those for atherosclerotic cardiovascular disease and …

Many retinal diseases and imaging findings have pathophysiologic underpinnings in the
function of the cardiovascular system. Myriad retinal conditions, new imaging biomarkers …

Myocardial infarction with nonobstructive coronary arteries (MINOCA) is a distinct subtype of
myocardial infarction (MI), occurring in about 8–10% of spontaneous MI cases referred for …